Trade name
DBL Dobutamine
Presentation and preparation
12.5 mg/mL (volume: 20 mL)
IV administration
Dilute to 5 mg/mL or weaker and give as a continuous infusion, preferably via a central line.
May be administered peripherally via a large vein in emergencies.
Administration via umbilical artery catheter is not recommended.
Refer to local guidelines.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Glucose 5%
Glucose 5% and sodium chloride 0.9%
Glucose 5% and sodium chloride 0.45%
Glucose 10%
Hartmann’s
Sodium chloride 0.9%
Y-site only:
Plasma-Lyte 148
Potassium chloride 20 mmol/L
Additional information
Extravasation risk.
Continuous cardiac monitoring required during administration. Use only when facilities for cardiac monitoring and cardio-respiratory resuscitation exist.
Taper the infusion slowly when discontinuing treatment; abrupt discontinuation may cause hypotension.
Solution should be clear and colourless to slightly yellow.
Solutions may exhibit pink discolouration but no significant loss of potency over 24 hours.
Protect from light during storage.
Discard any unused vial contents.